RecruitingNot ApplicableNCT06070870

Health Education Approach to Lung Screening

Health Education Approach to Lung Screening (HEALS)


Sponsor

Virginia Commonwealth University

Enrollment

675 participants

Start Date

Oct 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests a health education approach to encourage more Black and African American people to get lung cancer screening. Lung cancer is highly treatable when caught early, but screening rates are low. Researchers want to see if a targeted education program can help more eligible people get screened. **You may be eligible if...** - You identify as Black or African American - You meet the guidelines for lung cancer screening: you have a 20 pack-year smoking history (smoking a pack a day for 20 years, or equivalent), AND you currently smoke or quit within the past 15 years - You are in the eligible age range per current U.S. screening guidelines **You may NOT be eligible if...** - You do not meet the smoking history criteria - You do not identify as Black or African American (this study specifically targets this community) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPatient Navigation

Navigation will address the following 4 domains of barriers to screening: * Individual * Organizational * Economic * Sociocultural At the first visit, navigators will assess the participant's barriers in each of these domains. Any follow-up visits, if necessary, will be used to help the participant overcome these barriers to screening


Locations(3)

University of North Carolina-Chapel Hill

Carrboro, North Carolina, United States

Medical University of South Carolina

Charleston, South Carolina, United States

Virginia Commonwealth University

Richmond, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06070870


Related Trials